Natco Pharma Limited announced today, November 13, 2026, that its Board of Directors has approved a second interim dividend of ₹1.25 per equity share of ₹2 each for the financial year 2026-27. The record date for determining eligible shareholders is set for Thursday, November 19, 2026, with dividend payments commencing on November 27, 2026. This decision reflects the company’s healthy financial performance and commitment to returning value to its shareholders.
Natco Pharma Approves Second Interim Dividend
On November 13, 2026, the Board of Directors of Natco Pharma Limited convened a meeting where they considered and approved several key business items, including the declaration of a second interim dividend. This decision is a direct outcome of the company’s financial performance during the reported period.
Dividend Details
The Board has declared a second interim dividend of ₹1.25 (Rupees one rupee twenty-five paise only) per equity share. Each equity share has a face value of ₹2 (Rupees two only). This dividend is for the financial year 2026-27.
Record Date and Payment Schedule
The company has fixed Thursday, November 19, 2026, as the record date for identifying the shareholders who will be eligible to receive this interim dividend. The actual payment of the dividend will commence from November 27, 2026.
Unaudited Financial Results
As part of the board meeting, the unaudited financial results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026, were also considered and approved. These results were prepared in accordance with Indian Accounting Standards (IND-AS) and relevant SEBI regulations.
Meeting Conduct
The Board meeting commenced at 11:50 a.m. and concluded at 2:00 p.m. on the same day.
Source: BSE
